Company: GANX
Filing Date: 2025-02-06
Form Type: 8-K
Source: 0001104659-25-010148
Chunk: 1

Company: Gain Therapeutics, Inc.
Filing Date: 2025-02-06
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                  
         99.1      Press Release issued by Gain Therapeutics, Inc., dated February 6, 2025.     
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

   1  

SIGNATURE

Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.

  Dated: February 6, 2025      GAIN THERAPEUTICS, INC.                                                  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────
                               By:                          /s/ Gene Mack                               
                                                            Name:              Gene Mack                
                                                            Title:             Chief Executive Officer  

   2